{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":36,"n_cols":5,"rows_kept":36,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[5,2,5,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[12,2,12,3],[12,4,12,5],[13,2,13,3],[13,4,13,5],[14,2,14,3],[15,2,15,3],[22,2,22,3],[23,2,23,3],[24,2,24,3],[25,2,25,3],[26,2,26,3],[27,2,27,3],[31,2,31,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISALENTO991003985129707536"]
[null,null,"Titolo",null,"Codex publicorum (Codice del Piovego )"]
[null,null,"ISBN",null,"9788888055053"]
[null,null,"Descrizione fisica",null,"Venezia : [s. n.], 2006"]
[{"$nulls":4},"1 v.  ; 26 cm."]
[null,null,"Collana",null,"Fonti per la storia di Venezia. Sez. 1., Archivi pubblici"]
[{"$nulls":4},"Monumenti storici / pubblicati dalla, Deputazione di storia patria per le Venezie. N.S. ; 26"]
[null,null,"Disciplina",null,"344.453105233"]
[null,null,"Lingua di pubblicazione",null,"Italiano"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Vol. 2 / a cura di  Bianca Lanfranchi Strina."]
[null,"2.","Record Nr.",null,"UNINA9911019306403321"]
[null,null,"Titolo",null,"Anaphylaxis"]
[null,null,"Pubbl/distr/stampa",null,"Chichester ; ; Hoboken, NJ, : John Wiley & Sons, 2004"]
[null,null,"ISBN",null,"9786610271191"]
[{"$nulls":4},"9781280271199"]
[{"$nulls":4},"1280271191"]
[{"$nulls":4},"9780470861196"]
[{"$nulls":4},"0470861193"]
[{"$nulls":4},"9780470861158"]
[{"$nulls":4},"0470861150"]
[null,null,"Descrizione fisica",null,"1 online resource (308 p.)"]
[null,null,"Collana",null,"Novartis Foundation symposium ; ; 257"]
[null,null,"Disciplina",null,"614.5/993"]
[null,null,"Soggetti",null,"Anaphylaxis"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"Symposium on Anaphylaxis, held at the Novartis Foundation, 25-27 February 2003; editors, Gregory Bock (organizer) and Jamie Goode.\"--Contents p."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and indexes."]
[null,null,"Nota di contenuto",null,"ANAPHYLAXIS; Contents; Participants; Chair's introduction; History and classification of anaphylaxis; Discussion; Rethinking Th2 antibody responses and allergic sensitization; Discussion; General discussion I; The high affinity receptor for IgE, FceRI; Discussion; Effector cells of anaphylaxis: mast cells and basophils; Discussion; Cytokine enhancement of anaphylaxis; Discussion; General discussion II; Patterns of anaphylaxis: acute and late phase features of allergic reactions; Discussion; Fatal anaphylaxis in the UK, 1992-2001; Discussion; The human heart as a shock organ in anaphylaxis"]
[{"$nulls":4},"Discussion General discussion III; Food-induced anaphylaxis; Discussion; Anaphylaxis to insect venom; Discussion; Anaphylaxis to anaesthetic drugs; Discussion; General discussion IV; The radiocontrast molecule in anaphylaxis. A surprising antigen; Discussion; General discussion V Fatal course of Vespula venom immunotherapy: pretreatment withdrawal of the b blocker may have been involved; Epinephrine (adrenaline) in the first-aid, out-of-hospital treatment of anaphylaxis; Discussion; New approaches for the treatment of anaphylaxis; Discussion"]
[{"$nulls":4},"Patient's perspective and public policy regarding anaphylaxis "]
[{"$nulls":4},"Discussion; Final discussion; Index of contributors; Subject index"]
[null,null,null,"Sommario/riassunto","Anaphylaxis is an immediate-type allergic reaction involving the whole organism. It is the most life-threatening allergic condition. Although there are few exact epidemiological data regarding prevalence, estimates regarding insect sting anaphylaxis range from 1-3% in the general population, but much higher values have been reported by some authors for food and drug-induced anaphylaxis. Anaphylaxis is the main acute killer of allergic individuals.Although anaphylaxis was discovered at the beginning of the 20th century, there are still many unresolved issues. These include non-IgE-mediated"]